razormd

3 Positives From Vanda's Conference Call

That's the same CC "doublespeak" that every biotech firm uses...if Novartis and Titan didn't want iloperidone then why on earth do you think ANYONE else would?...why would anyone want to partner VEC-162 when it is basically NOTHING more than the already approved ramelteon?...pull your head out of your deluded MBA butt long enough to read the history of those two drugs...NO ONE is going to want to partner with VNDA!...of course, management won't say that until AFTER they have collected as many options as possible and AFTER they have sold as much stock as possible!...have you noticed that the CEO alone has sold about 6 MILLION bucks worth of stock in the past year?

NeurogesX, Vanda Would Do Well To Find Themselves A Partner

I post a great deal on the Yahoo boards and have warned investors about companies like ANX, NUVO and many others months before pertinent news was released...you, in particular, may have seen my Yahoo posts over the past nine months warning about SNUS and its idiotic Vitamin E formulations...if you did then apparently you ignored them...too bad for your wallet...regardless, I think VNDA is basically another biotech scam...it licenses some throwaway drugs from other companies in an effort to con investors into believing because they are farther along in trials, the drugs have some merit...however, iloperidone is only a respiridone knock-off tossed by Novartis after lawsuits arose against Titan Pharmaceutical...VEC-1... is little more than ramelteon in disguise...VSF-173 is another one from the Novartis garbage can and looks like it's probably little more than a dopamine agonist...is there a course in your MBA program for assigning value to someone else's garbage?...moreover, the company's CEO is a geneticist with ZERO experience running a company and ZERO experience getting drugs approved...sorry, but this company looks like it was designed for nothing more than bilking investors.